beat

Hailshadow Johnson & Johnson (NYSE:JNJ) announced Tuesday that its FDA-approved cell therapy Carvykti, developed with Legend Biotech (LEGN), outperformed standard of care in a Phase 3 trial for patients with a type of blood cancer called multiple myeloma. Citing interim data from its CARTITUDE-4 trial, the pharma giant said patientsContinue Reading

LewisTsePuiLung/iStock Editorial via Getty Images BYD (OTCPK:BYDDF) has set a new sales record in the second quarter, driven by price cuts across most models, and is inching closer towards overtaking Tesla (TSLA) once again as the world’s top seller of electric vehicles. The Chinese EV maker sold 426,039 pure EVsContinue Reading